Dr. Mills is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9201 W Sunset Blvd
Ste 812
West Hollywood, CA 90069Phone+1 310-550-1010Fax+1 310-550-0650
Education & Training
- University of California (San Francisco)Residency, Anesthesiology, 1986 - 1989
- Duke University School of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 1999 - 2025
- FL State Medical License 1994 - 1996
- American Board of Anesthesiology Anesthesiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
Clinical Trials
- Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients Start of enrollment: 2012 Mar 01
- Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Start of enrollment: 2013 Feb 01
- Evaluating BMD in Participants ≥50 Years Old Switching From EVG/COBI/FTC/TAF or EVG/COBI/FTC/TDF to ABC/DTG/3TC Start of enrollment: 2016 Jul 01
Publications & Presentations
PubMed
- 348 citationsCo-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infect...Paul E. Sax, Edwin DeJesus, Anthony Mills, Andrew R. Zolopa, Calvin J. Cohen
Lancet. 2012-06-30 - 71 citationsSuperior Efficacy and Improved Renal and Bone Safety After Switching from a Tenofovir Disoproxil Fumarate- to a Tenofovir Alafenamide-Based Regimen Through 96 Weeks of...Edwin DeJesus, Bernard Haas, Sorana Segal-Maurer, Moti Ramgopal, Anthony Mills
AIDS Research and Human Retroviruses. 2018-04-01 - 66 citationsA week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.Joseph J. Eron, Chloe Orkin, Joel E. Gallant, Jean-Michel Molina, Eugenia Negredo
AIDS. 2018-07-17
Press Mentions
- Trial Site Network Platinum Research Network Expands to West Coast as Diversity & Infectious Disease Specialist Mills Clinical Research JoinsMay 29th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: